iovera System— 510(k) K220656

Substantially Equivalent

Pacira Biosciences, Inc.

FDA 510(k) clearance K220656 for iovera System, Substantially Equivalent on 2022-05-20. Applicant: Pacira Biosciences, Inc..

Clearance details

Applicant: Pacira Biosciences, Inc.
Product code: Code GXH
Advisory panel: Neurology
Date received: 2022-03-07
Decision date: 2022-05-20
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.